TCT Session

Alan Wilson and Szeto Zajarias show that vascular complications of the trans-femoral path remain an important factor because of the high profile of the catheters used in TAVI and the appearance of smaller devices, as well as the experience of surgeons, will progressively reduce complication rates. 

Josep Rodes-Cabau commented about the negative impact a stroke has over the procedure and prevention strategies for embolism that are being developed to reduce the incidence of periprocedural stroke

Thomas Gleason was devoted to the incidence and impact of post-procedural paravalvular aortic regurgitation (AR), showing that moderate aortic regurgitation was found in 24.7% of patients and that is an independent predictor of mortality both in the short term and long term. This can be corrected by post dilatation or implantation of a second prosthesis. 

Samir Kapadia R., commented on coronary occlusion that may occur during delivery of the stent, a rare complication, (0.6 to 1%), but potentially fatal. 

Philippe Genereux addressed the defective position, migration and device embolization. Although rare, (1.7% of cases), this complication increases morbidity and mortality and can lead to coronary obstruction, severe aortic failure, conduction disturbances, strokes, aortic dissection, vascular complications and bleeding. Embolization is most common when the procedure is performed trans-femoral versus trans-apical. He concludes that it is essential to plan with an imaging procedure to decrease the rate of embolization and defective position. New devices will significantly reduce the rate of this complication. 

This session demonstrated how the complications of TAVI impact on prognosis over the short-term and long term due to the profile of patients, the severity of these complications, the preoperative preparation procedure, the choice of prosthesis with all measures taken (preferably by more than one method), the experience of professionals in this procedure and knowledge of the anatomy of the femoral and iliac aorta area to choose ideal access thus leading to a decrease in these complications and an ever improving performance.

2013-03-09

More articles by this author

TCT Session. An assessment of the severity of lesions. A debate about the different methods to assess coronary physiology.

FFR is the gold standard (Dr. William Fearon) Dr. William reported on the benefits of using FFR:  • A high degree of accuracy in identifying lesions...

PREVAIL: LAA occlusion versus anticoagulation with warfarin to prevent stroke in patients with non-valvular atrial fibrillation.

An hour before the presentation of the PREVAIL study, the ACC announced the cancellation of the release of the study results. Due to an...

THRIVE: Niacin/laropiprant extended release showed no significant cardiovascular benefit.

The THRIVE study, (also known as HPS2-THRIVE), was a multicenter clinical trial designed to test the hypothesis that the increase in HDL, (using ER...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....